Shares of microcap biotech developer Adeona Pharmaceuticals (AEN) soar over 23% after reporting...


Shares of microcap biotech developer Adeona Pharmaceuticals (AEN) soar over 23% after reporting successful results from its pilot Phase I/II safety study of oral high dose zinc therapy in ALS, also known as Lou Gehrig's disease.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs